BE of Euthyrox® Tablets (Merck Nantong Versus Merck Darmstadt Sites)

Phase 1 Completed 56 enrolled Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to demonstrate bioequivalence (BE) between Euthyrox® tablets manufactured at Merck Nantong (Test Euthyrox) versus the tablets manufactured at Merck Darmstadt (Reference Euthyrox).

Timeline

Start: 2022-01-10
Primary completion: 2022-10-18
Completion: 2022-10-18

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Levothyroxine	Other / unclassified	50 ug	Oral

Indications

No indication recorded.